Maryland 2026

SB 562

State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

Official record

Measure details

Jurisdiction: Maryland
Session: 2026
Chamber: upper
Classification: bill
Subjects: Committees and Commissions, Contracts, Controlled Dangerous Substances, Data, Disclosure, Drugs, Federal Government, Health Occupations, Job Training, Midwives, Opioids, Pharmacists and Pharmacies, Public Health, Registration, Substance Abuse Treatment
Introduced / first action: 2026-02-04 00:00:00

2026-04-14 00:00:00
Approved by the Governor - Chapter 54
executive-signature
2026-04-03 00:00:00
Returned Passed
2026-04-02 00:00:00
Third Reading Passed
passage
2026-04-01 00:00:00
Favorable Adopted Second Reading Passed
committee-passage-favorable
2026-04-01 00:00:00
Favorable Report by Health
committee-passage-favorable
2026-03-17 00:00:00
Hearing 3/25 at 1:00 p.m.
2026-03-13 00:00:00
Referred Health
referral-committee
2026-03-12 00:00:00
Third Reading Passed
passage
2026-03-10 00:00:00
Second Reading Passed with Amendments
2026-03-10 00:00:00
Favorable with Amendments {
committee-passage-favorable
2026-03-09 00:00:00
Favorable with Amendments Report by Finance
committee-passage-favorable
2026-02-12 00:00:00
Hearing 3/03 at 1:00 p.m.
2026-02-04 00:00:00
First Reading Finance
referral-committee

Documents and versions

Recorded votes

When supplied by the API

Traceable provenance

Provider updated: 2026-10-30 15:56:00. Locally fetched: 2026-11-07 06:28:26.